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ABSTRACT 
Regulators of chromatin dynamics and transcription are increasingly implicated in the aetiology 
of neurodevelopmental disorders (NDDs). Haploinsufficiency of EHMT1, encoding a histone 
methyl-transferase, is associated with several NDDs, including Kleefstra syndrome, 
developmental delay and autism spectrum disorder. Using a mouse model of Ehmt1 
haploinsufficiency (Ehmt1D6Cre/+), we examined a number of brain and behavioural 
endophenotypes of relevance to NDDs. Specifically, we show that Ehmt1D6Cre/+ mice have 
deficits in information processing, evidenced by abnormal sensory-motor gating, a complete 
absence of object recognition memory and a reduced magnitude of auditory evoked potentials in 
both paired-pulse inhibition and mismatch negativity (MMN). The electrophysiological 
experiments show that differences in magnitude response to auditory stimulus were associated 
with marked reductions in total and evoked beta- and gamma-band oscillatory activity, as well as 
significant reductions in phase synchronisation. The pattern of electrophysiological deficits in 
Ehmt1D6Cre/+ matches those seen in control mice following administration of the selective 
NMDA-R antagonist, ketamine. This, coupled with reduction of Grin1 mRNA expression in 
Ehmt1D6Cre/+ hippocampus, suggests that Ehmt1 haploinsufficiency may lead to disruption in 
NMDA-R. Taken together, these data indicate that reduced Ehmt1 dosage during forebrain 
development leads to abnormal circuitry formation, which in turn results in profound information 
processing deficits. Such information processing deficits are likely paramount to our 
understanding of the cognitive and neurological dysfunctions shared across the NDDs associated 
with EHMT1 haploinsufficiency.  
 
Keywords: Neurodevelopmental disorders; mouse model; startle and PPI; auditory event related 
potentials; NMDA-R hypofunction 
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INTRODUCTION 
Post-translational modifiers of histone proteins influence chromatin dynamics and transcriptional 
regulation throughout development and are essential for the highly choreographed processes of 
lineage commitment and differentiation during neurodevelopment (Tyssowski et al., 2014, 
Hirabayashi and Gotoh, 2010).  Perhaps unsurprisingly, exome sequencing studies and pathway 
analyses of genome wide association studies implicate genes encoding chromatin and 
transcriptional regulators in the aetiology of autism spectrum disorders (RK et al., 2017, De 
Rubeis et al., 2014), schizophrenia (Network and Pathway Analysis Subgroup of Psychiatric 
Genomics, 2015) and severe developmental disorders (Singh et al., 2016, Deciphering 
Developmental Disorders, 2017). One such gene, implicated in several neurodevelopmental and 
neuropsychiatric disorders (Talkowski et al., 2012), is EHMT1, which encodes the histone H3 
lysine 9 mono- and di-methyltransferase G9a-like protein (GLP). 
Haploinsufficiency of EHMT1 is the primary cause of the 9q34 subtelomeric-deletion syndrome, 
also known as Kleefstra Syndrome (Kleefstra et al., 2006, Kleefstra et al., 2005), a condition 
associated with intellectual disabilities, epilepsy, childhood hypotonia, facial dysmorphism, 
microcephaly, delays in reaching developmental milestones and behavioural problems such as 
aggressive outbursts and hypoactivity. Furthermore, analysis of Copy Number Variants (CNVs) 
(Cooper et al., 2011) and a large exome sequencing study (Deciphering Developmental 
Disorders, 2017) have linked de novo mutations affecting EHMT1 to severe developmental delay 
more generally. Finally, CNVs spanning EHMT1 have also been associated with autism 
spectrum disorder (O'Roak et al., 2012) and schizophrenia (Kirov et al., 2012). 
The importance of Ehmt1 in brain function is supported by data from animal models that 
demonstrate a range of behavior changes reminiscent of neurodevelopmental disorders including 
exploration and/or anxiety phenotypes (Balemans et al., 2010, Schaefer et al., 2009), and 
abnormal learning and memory (Iacono et al., 2018, Benevento et al., 2017, Balemans et al., 
2013, Kramer et al., 2011). More recently, studies using rodent neuronal cultures and ex vivo 
slices (Benevento et al., 2016), and human iPSCs (Frega et al., 2019), have shown that 
appropriate expression of EHMT1 is required for the correct establishment and function neuronal 
networks. In human iPSCs, this neuronal network dysfunction is driven by the abnormal 
expression of GRIN1 expression and enhanced NMDA-R signaling (Frega et al., 2019). 
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Here we explore endophenotypes of relevance to psychiatric problems seen in those carrying 
mutation of EHMT1, using a mouse model of Ehmt1 haploinsufficiency (Ehmt1D6Cre/+ mice). In 
order to reduce anatomical complexity and allow a more precise focus on the impact of Ehmt1 
haploinsufficiency during development, on later behavioural and neurophysiological parameters, 
we generated a forebrain-specific Ehmt1 knockout mouse. Cre recombination was driven under 
the D6 promoter of the Dach1 gene limiting Ehmt1 heterozygous deletion to the forebrain, 
starting at embryonic stage 10.5 in the cortical vesicles (van den Bout et al., 2002, Machon et al., 
2002). Specifically, we find deficits in sensory motor-gating and novel object recognition, and 
decreased anxiety. We then build upon recent in vitro and ex vivo evidence of abnormal neuronal 
networks and show a reduction in the magnitude of auditory evoked potentials in paired-pulse 
inhibition and mismatch negativity, providing in vivo electrophysiological evidence of an 
impairment in information processing in the Ehmt1D6Cre/+ mice. Gene expression data and 
pharmacological manipulation support the general idea that abnormal NMDA-R signalling in 
Ehmt1D6Cre/+ adult mouse contributing to the sensory-motor gating and information processing 
deficits. 
 
MATERIALS AND METHODS 
Animals 
All procedures were conducted in accordance with the requirements of the UK Animals 
(Scientific Procedures) Act 1986, with additional ethical approval at Cardiff University.  
In order to generate experimental cohorts, Ehmt1fl/fl (Schaefer et al., 2009) male studs were 
paired in trios with one homozygous females carrying two copies of the Tg(Dach1-cre)1Krs/Kctt 
Cre transgene, maintained on a F1(C57BL/6J x CBA/Ca) background; and one wild-type 
F1(C57BL/6J x CBA/Ca) female.  The Ehmt1D6Cre/+ mouse model was used in order to limit the 
effects of the deletion to the forebrain and hippocampus only and confounding effects of the non-
CNS phenotypes, such as obesity (Balemans et al., 2010). Experimental cohorts were reared 
together and then weaned into mixed cages (2-5per cage) of Ehmt1D6cre/+ (experimental line) and 
Ehmt1fl/+ mice (control line). All experimental subjects were male mice, and aged between 4-6 
months during behavioural testing. A subset of the behavioural cohort were subsequently used in 
the electrophysiology experiments (7-8 months). Animals were housed 12 hour light/12 hour 
 5 
dark (lights on at 7am), and standard laboratory diet and water were available ad libitum 
throughout testing.  Experimenters were blind to the genotype of animals during behavioural 
testing. 
 
Behaviour 
All animals were initially subject to sensory-motor gating testing (Ehmt1fl/+, n=25; Ehmt1D6cre/+ 
mice, n=31). A subset of these were then subsequently tested on the rotor-rod (Ehmt1fl/+, n=9; 
Ehmt1D6cre/+ mice, n=18) and then elevated plus maze and open field.  The remainder of the 
animals were subsequently tested on the novel object recognition memory test (Ehmt1fl/+ mice, 
n=16; Ehmt1D6cre/+ mice, n=13).  
Sensory-motor gating 
Acoustic startle response (ASR) and prepulse inhibition (PPI) of the startle response were 
monitored using a SR-Lab apparatus (San Diego Instruments, U.S.A) modified for use in mice, 
according to published methods (McNamara et al., 2016). Briefly, animals were placed in a 
Perspex tube (internal diameter 35mm) and white noise stimuli were presented via a speaker. 
The amount of movement relayed as their startle response was measured as a piezoelectric 
measure converted to arbitrary startle units. The measurement used was the maximum startle 
(Vmax). Due to the effect of weight on this reflex movement measurement, all data was 
normalised for individual body weight. Pulse-alone trials consisted of a 40ms 120dB startle 
stimulus and a prepulse trial consisted of a 20ms prepulse at 4, 8, or 16db above background and 
a 40ms 120db startle stimulus, 70ms after the prepulse. The stimuli were presented in a 
pseudorandom manner every 15s. Whole body startle responses were recorded as the average 
startle during a 65ms window timed from the onset of the startle pulse. 
Percentage PPI score for each trial was calculated: 
[%PPI=100 × (ASRstartle pulse alone − ASRprepulse + startle pulse)/ASRstartle pulse alone]. 
Rotarod testing 
A rotarod task (Ugo Basile, Italy) was used to assess motor learning and co-ordination. This 
consisted of a rotating rod 30 mm in diameter, with five separated chambers 57 mm in width, 
with a rod elevation of 160 mm. Motor learning was assessed across six rotarod sessions, one 
morning session and one evening session, on three consecutive days. The rod speed accelerated 
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incrementally from 5-50rpm across the 300sec session. The main measure during training was 
latency to first fall. However, if the mice fell, they were continuously replaced on the rotating 
rod, until the full 300sec-session was over in order to prevent any confounds from arising from 
overall differences in time spent on the rotarod across sessions.  In a separate test session on day 
four, the mice were given one 300-sec session at 10rpm, 20rpm, 30rpm, 40rpm and 50rpm 
consecutively in one morning session in order to assess motor coordination. Again the latency to 
first fall was recorded for each animal at each speed.  
Novel object recognition memory 
The NOR test arena was a square 30cm x 30cm with 30cm high, white Perspex walls. Four 
different, non-displaceable objects were used. All objects were white and selected for their equal 
appeal and available in triplicate to avoid the use of olfactory cues.  In the habituation phase, 
24hr prior to the task, each subject was allowed to explore the arena for 10min in the absence of 
objects. In the acquisition phase, the subject was returned to the arena containing 2 identical 
sample objects (A, A’) and given 10min to explore.  After a retention phase, consisting of 15min 
or 90min, the subject was returned to the arena with two objects, one identical to the sample and 
the other novel (A, B). During both the familiarization and test phase, objects were located 
adjacent corners of the arena. The location of the novel object was counterbalanced. To prevent 
coercion to explore the objects, the subject was released in a third corner. Objects were cleaned 
with 70% ethanol wipes between sessions and object selection was randomized.  
The main measure used was the Recognition Index (RI), indicating whether the animal 
investigated the novel object more than chance. This was calculated by the percentage of time 
spent investigating the novel object relative to the total object investigation [RI= TN/(TN+TF ) x 
100]. An RI significantly above chance or 50% indicates recognition of novelty and an RI equal 
to or below 50% indicates either no preference for the novelty or no recognition of novelty. 
Other parameters recorded were:overall time spent with each object, and frequency of visits to 
the zones containing an object. Data was collected in 1-min time bins across the 10-min session 
by a camera linked to a computer with Ethovision Observer software (Noldus, Nottingham, UK). 
 
Electrophysiology 
Adult male Ehmt1D6Cre/+ mice (n=7) and Ehmt1fl/+ control cage-mates (n=7) at 6-7 months of age 
were anesthetized with 2% isoflurane for stereotaxic electrode implantation. The electrode 
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configuration used two bilateral frontal electrodes, one monopolar and one bipolar (2.7-mm 
anterior, 1.5-mm lateral, 1.2-deep relative to bregma); two bilateral hippocampal electrodes, one 
monopolar and one bipolar (2.7 mm posterior, 3-mm lateral, 2.2-mm deep relative to bregma); 
and one bipolar electrode in the auditory cortex (2.7-mm posterior, 4-mm lateral, 1.1-deep 
relative to bregma) as has been previously reported (Ehrlichman et al., 2008, Siegel et al., 2003) 
(for further details see Supplementary Figure 1). Due to animal loss, a subset of these was used 
in the MMN study; Ehmt1D6Cre/+ mice (n=5) and Ehmt1fl/+ control cage-mates (n=5). 
ERPs were obtained by averaging EEG traces centred at time 0 and 500msec to 0μV, 
respectively. For each trial, power was calculated by using a complex Morlet’s wavelets w(t, f0) 
(Kronland-Martinet et al., 1987). The script used can be found at 
https://www.physics.lancs.ac.uk/research/nbmphysics/diats/tfr/. The wavelets have a Gaussian 
shape in the time domain (SD σt) and in the frequency domain (SD σt) around its central 
frequency ƒ0: w(t, f0)=A * exp(-t2/2 σt2) * exp(2iπf0t) with σf=1/πσt. The wavelet family we 
used was defined by f0/σf=1, with f0 ranging from 0.5 to 100Hz in logarithmically distributed 
frequency steps (for full details see Supplementary Information - Materials and Methods).  
Auditory stimuli were generated using Spike2, version 7.2 and a Power1401 interface (CED, 
UK). Auditory stimulus was delivered with speakers positioned directly in front of each 
recording cage. Each mouse received an auditory, paired-pulse session and two sessions of 
mismatch negativity (MMN).  
Paired pulse 
Following Halene et al. (Halene et al., 2009), each mouse received an auditory, paired-pulse 
session in which a single tone was presented at 1500Hz and 90dB (S1) followed by a 500ms 
intra-trial interval and a second tone at 1500Hz and 90dB (S2). The tones were sinusoidal and 
10ms in duration. The inter-pulse interval between the two tones was 10-s. Each mouse received 
1250 paired-pulse trials per recording session. 
Mismatch negativity 
The mice also received two sessions of the MMN protocol. Similar to Ehrlichman et al. 
(Ehrlichman et al., 2008), the mice received 24 ‘standard’ tones at 90dB and 1500Hz and one 
‘deviant’ tone at 90dB and 2000Hz. All tones were sinusoidal and 10ms in duration and the 
intra-pulse interval between the 25 tones was 500-ms, while the inter-trial interval was 5-s. Each 
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mouse was recorded for 360 trials in each of two sessions. In one session 10mg/kg of Ketamine 
was administered and in the second session an equal volume of saline was administered. The 
dosage of ketamine was chosen based on previous work (Ehrlichman et al., 2008, Siegel et al., 
2003). The within group design was counterbalanced by genotype and the order in which 
ketamine or saline sessions were administered. All recordings took place 5-mins after 
intraperitoneal injections of either 10mg/kg ketamine or the volume equivalent dose of saline. 
The waveform channels were filtered between 1 and 500Hz. 
Gene Expression 
RNA was extracted from macrodissected hippocampi using the RNeasy micro kit (Qiagen) 
following the manufacturers instructions. A 96 well RT2 Custom Profiler PCR Array 
(CAPM12608, Qiagen) for mice was used. The custom genes list was generated based on GLP 
targets identified in the literature and tissue-specific relevance. For the qPCR array 1μg of total 
RNA was used and manufacture’s instructions were followed, for cDNA synthesis—RT2 First 
Strand Kit (Qiagen) and for the RT-PCR reaction—RT2 SYBR Green ROX qPCR Matermix 
(Qiagen). The average Ct values across the three housekeeping genes B2m, B-actin and Gapdh 
were used as endogenous controls. ΔCt values were generated by normalizing to the geometric 
mean of the Ct values for these three housekeeping genes.  All individual reactions were carried 
out in triplicate. Real time qPCR data was visualized using the ΔΔCt method (Livak and 
Schmittgen, 2001). 
Statistics 
All data were analyzed using SPSS 20 (SPSS, USA). The statistical differences between groups 
were analysed using independent samples t-tests, ANOVAs, or where appropriate Repeated 
Measures ANOVA (RP-ANOVAs). The main between-subject factor was GENOTYPE 
(Ehmt1fl/+ controls or Ehmt1D6Cre/+). The following within-subject factors were also analysed: 
TRIAL (Startle trial); PREPULSE (4, 8 or 16dB); SESSION and SPEED (rotarod); PULSE 
(standard or deviant in the MMN). To check for normal distribution, Mauchly’s test of sphericity 
of the covariance matrix or Levenes test for equality of variances were applied. The more 
conservative Huynh-Feldt corrections, with adjusted degrees of freedom are reported in cases in 
which test assumptions were violated. Non-parametric analyses were as follows. For the NOR 
task, the binomial distribution one sample Kolmogorov Smirnov (KS) test was applied to 
determine whether average RIs or SIs were significantly above chance (above 50%). For analysis 
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of N1 amplitude, Wilcoxon rank-sum test was used. Statistical tests on the electrophysiological 
time-frequency data were performed using the permutation method with <1,000 iterations 
(Westfall and Young, 1993) (see Supplementary Information – Materials and Methods for full 
details). For all comparisons, alpha value was set at p<0.05. 
 
RESULTS 
Impaired sensory-motor gating in Ehmt1D6Cre/+ mouse 
The acoustic startle response and pre-pulse inhibition (PPI) of this response, were used to 
examine sensory-motor function in the Ehmt1D6Cre/+ mice.  Over the course of six consecutive 
auditory pulse (120dB) startle trials, Ehmt1D6Cre/+ mice had, on average, twice the startle response 
compared to Ehmt1fl/+ mice (Figure 1A; ANOVA, main effect of GENOTYPE, F1,53=6.86, 
p=0.01). A significant interaction between GENOTYPE and TRIAL (F3.87,201.0=2.48, p=0.03) 
indicated different patterns of startle reactivity and habituation relative to Ehmt1fl/+ mice. Post 
hoc analysis revealed that there was an equivalent startle response to the initial trial between 
genotypes (p=0.68), but on average Ehmt1D6Cre/+ mice showed a significantly enhanced startle 
response in all consecutive trials (trial 2, p=0.05; 3, p=0.01; 4, p=0.001; 5, p=0.01; and 6, 
p=0.02). 
As expected, increasing the prepulse volume led to a linear increase in the inhibition of the 
startle in both groups (Figure 1B; ANOVA, main effect of PREPULSE, F1.49,80.35=73.26, 
p=0.001). However, there was a 20-40% PPI reduction in the Ehmt1D6Cre/+ mice relative to 
Ehmt1fl/+ cage-mates (Figure 1B; ANOVA main effect of GENOTYPE, F1,54=5.54, p=0.022), 
suggesting that, in addition to an enhanced startle response, the mutant mice were also impaired 
in the normal PPI response 
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Figure 1. Sensory-motor gating & motor learning and coordination.  A) The startle response after 6 
consecutive 120dB pulse stimulations show Ehmt1D6Cre/+ mice (n=31) had a significantly higher overall maximum 
startle response in all trials. B) Prepulse inhibition of the startle response generally increased with the increasing 
volume of the prepulse as expected. However, Ehmt1D6Cre/+ displayed a 20-40% reduction in PPI of startle relative 
to Ehmt1Fl/+ mice (n=25) C) Both Ehmt1Fl/+ (n=9) and Ehmt1D6Cre/+ mice (n=18) improved motor ability on the 
rotarod as evidenced by an increase in latency to fall across 6 training sessions. There was no also difference in 
genotype during training D) In a probe test where rotarod speed accelerated throughout the session, there was a 
general decrease in the latency to fall as the speed increased, but again no difference between genotypes. Data are 
mean ±SEM, or box-plots showing median (solid line), mean (dotted line) and 10th, 25th and 75th and 90th 
percentiles. * represents main effect of GENOTYPE p<0.05; ## represents main effect of within-subject factor 
(TRIAL, PREPULSE, SESSION or SPEED). 
 
Normal motor function in the Ehmt1D6Cre/+ mouse 
Altered sensory-motor gating in Ehmt1D6Cre/+ mice was not due to any gross deficits in motoric 
competence. Training on the rotarod test indicated normal learning with repeated sessions, with 
latency to fall reducing across training sessions (Figure 1C; ANOVA, main effect of SESSION, 
F5,130=21.33, p<0.001), but there was no difference in GENOTYPE (F1,26=0.12, p=0.73) and no 
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interaction between training SESSION and GENOTYPE (F5,130=0.67, p=0.65). Moreover, in an 
accelerating rotarod probe test of motor coordination, latency to fall decreased as the speed 
increased (Figure 1D; ANOVA, main effect of SPEED, F4,104=38.38, p<0.001), but there was no 
difference between GENOTYPE (F1, 26=0.67, p=0.42) or interaction between SPEED and 
GENOTYPE (F4,104=0.65, p =0.63). 
 
Reduced anxiety in the Ehmt1D6Cre/+ mouse 
A number of measures in the elevated plus maze and open field tests indicated that Ehmt1D6Cre/+ 
mice have a reduced anxiety phenotypes. On the EPM (Figure 2A and B) Ehmt1D6Cre/+ mice 
spent on average twice as long as Ehmt1Fl/+ cage-mates on the open-arm (t26 =-2.08,  p = 0.04) 
and made on average 40% more entries into the open arm of EPM more than controls, although 
this did not reach statistical significance (t26  = -1.52,  p = 0.14). On the OF test (Figure 2C and 
D), Ehmt1D6Cre/+ mice made on average 25% more entries in the inner zone of the OF (t26= -3.21, 
p = 0.004) and spent 50% more time in the inner zone than Ehmt1Fl/+ mice, although this did not 
reach statistical significance (t26=-1.86, p=0.07). 
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Figure 2. Behaviour in the elevated plus maze and open field. On the EPM Ehmt1D6Cre/+ mice (n=17) showed a 
pattern of behaviour consistent with reduced anxiety relative to Ehmt1Fl/+ mice (n=9), including increased open 
arm entries (A) and increased time on time on the open arm (B), although only the latter was statistically different 
from controls.  Convergent evidence of a reduced anxiety phenotype was seen in the OF test. Here Ehmt1D6Cre/+ 
mice made significantly more entries into the centre of the OF (C) and spent more time in the inner zone (D), 
although this did not reach significance. Box-plots showing median (solid line), mean (dashed line) and 10th, 25th 
and 75th and 90th percentiles; * represents main effect of GENOTYPE p<0.05; ** p<0.01. 
 
Impaired novel object recognition in Ehmt1D6Cre/+ mouse 
The novel object recognition (NOR) task takes advantage of the preference of rodents to attend 
to new objects in their environment as a means for testing declarative memory (Antunes and 
Biala, 2012). Here, two inter-trial intervals were used: half of the cohort was examined following 
a 15-minute delay between the initial object exposure and the test trial, and half the cohort was 
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examined after a 90-minute delay. In the test phase, as expected the Ehmt1fl/+ control mice 
explored the novel object significantly more than chance (50%) in both the 15-minute and 90-
minute retention trials (Figure 3; Kolmogorov Smirnov test (KS), 15min, 60%, p=0. 02; 90min 
retention trial, 67%, p=0.002). However, exploration of the novel object by Ehmt1D6Cre/+ mice 
was not significantly above chance, at either 15min (52%, p=0.97), or 90 min retention trial 
(50%, p=0.44). 
This difference at test was not due to differences during the habituation phase, as indicated by 
overall exploration time of the object that was replaced by a novel object at test (Ehmt1fl/+ 
mean=114s,  ±SEM=15;  Ehmt1D6Cre/+ mean=113s ±SEM=12; ANOVA, no main effect of 
GENOTYPE, F1,28=0.031, p=0.86).  
 
Figure 3. Novel object recognition. In both the 15-minute and 90-minute retention tests of the NOR task 
Ehmt1fl/+ control mice (n=16) explored the novel object more than chance. However, exploration of the novel 
object by Ehmt1D6Cre/+ mice (n=13) was not significantly above chance, for either the 15- or 90-minute retention 
trials indicating a deficit in declarative memory. Data are box-plots showing median (solid line), mean (dotted 
line) and 10th, 25th and 75th and 90th percentiles (dots represent 5th and 95th percentile). * represents main effect of 
GENOTYPE p<0.05; ** p<0.01.  
 
Electrophysiological measurements of paired pulse AEPs 
In order to gain an insight into the neural changes underpinning the deficits in sensory-motor 
gating seen in Ehmt1D6Cre/+ mice we used electrophysiological methods. A subset of the 
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behavioural cohort was then subject to EEG recording to measure auditory evoked potentials 
(AEPs). AEPs are voltage fluctuations time-locked to an auditory event used for brain 
dysfunction clinical diagnosis  (Luck et al., 2011). We used a paired pulse paradigm in which 
two pulses were delivered back-to-back with a 500ms interval between the first stimulus (S1) 
and the second stimulus (S2) (Figure 4A). The grand average waveforms show a stereotypic 
maximal positive deflection (P1) and maximal negative deflection (N1) (Figure 4B1). 
Ehmt1D6Cre/+ mice had a nearly two-fold lower N1 amplitude response after the S1 (Figure 4B1) 
but not after S2 (Figure 4B2). Additionally, Ehmt1D6Cre/+ mice had a significant reduction in the 
S2/S1 ratio for the N1 component (Wilcoxon, rank sum=64, p=0.018), what is considered an 
electrophysiological measurement of sensory gating (Figure 4C). During peak activation of the 
paired pulse experiment we observed an increase in total power across high frequency bands 
from 10-100Hz in both groups of mice (Figure 4D1 and D2). The difference time-frequency plot 
and the permutation test between Ehmt1D6Cre/+ and Ehmt1fl/+ control mice however, revealed that 
the distributed peak that occurred approximately 40ms after the S1 pulse, a time corresponding 
with the N1, was significantly greater in the beta (13-30Hz) and gamma (30-70Hz) frequency 
bands in the Ehmt1fl/+ control mice (Figure 4G1 and G2). The late (>200ms after the S1 pulse) 
decrease in the delta frequency band (~4Hz) prominent in Ehmt1fl/+ (Figure 4D1-G1) was not 
different from Ehmt1D6Cre/+ (Figure 4G2). 
Measurements of evoked power, EEG power which is phase-locked with the event onset across 
trials, demonstrated increases in the delta (~4hz), beta (13-30Hz) and low gamma (here ~40Hz) 
band responses in both groups of mice approximately ~30-50 ms after the S1 (Figure 4E1 and 
E2). Again, permutation tests revealed a reduction in evoked power in Ehmt1D6Cre/+ mice after 
both the S1 and ~40ms after the S2 pulse (Figure 4H1 and H2). In complement, we measured the 
phase locking factor (PLF), which provide a measurement of trial-to-trial reliability across the 
frequency domain (Goffin et al., 2014). To extract the PLF, magnitude information is 
transformed to 1 and averaged so that the phase angle with respect to event onset is extracted 
(Roach and Mathalon, 2008). Values between zero and one are obtained, in which one reflects 
perfect synchrony of phase angles across trials. Ehmt1D6Cre/+ mice did not show PLF values above 
.17 at any point, while control mice show nearly two-fold PLF synchrony (+.25) at ~40ms post-
S1 pulse, between ~20-40Hz. Overall Ehmt1D6Cre/+mice demonstrated reduced PLF (Figure 4F1 
and F2). 
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Figure 4. AEP paired pulse measurements. A) Schematic showing the paired pulse stimulus paradigm. B1) 
Grand average ERP waveform after pulse 1 (S1) in Ehmt1D6Cre/+(red) and Ehmt1fl/+ (black). The P1 and N1 
components are indicated on the waveform. B2) The waveforms for pulse 2 (S2); C) N1 amplitude for 
Ehmt1D6Cre/+ (n=7) and Ehmt1fl/+ (n=7) mice. D1 & D2) Normalized total power (in time-frequency plot) of both 
S1 (time 0) and S2 (time 500ms) for Ehmt1fl/+ (D1) and Ehmt1D6Cre/+ (D2).  Note the early increase in the 
beta/gamma range  (10-100Hz) and the late decrease in the delta range (~4Hz) and the reduction of both 
components in the Ehmt1D6Cre/+. E1 & E2) Evoked power time-frequency plots for the same data set; F1 & F2) 
Phase locking factor for the same data set; G1) Difference of total power between Ehmt1fl/+ and Ehmt1D6Cre/+. G2) 
Statistical significance heat map based on permutation tests of total power are indicated by the colour scale (p-
value < 0.05);  H1) Difference of evoked power between Ehmt1fl/+ and Ehmt1D6Cre/+ mice; H2)  Statistical 
significance between evoked power of Ehmt1fl/+ and Ehmt1D6Cre/+  mice (spurious spots above 50Hz are due to 
occasional 50Hz noise contamination in some of the recordings). Data shown is mean ±SEM. 
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Electrophysiological measurements of Mismatched Negativity AEPs 
The Mismatch Negativity (MMN) response is elicited when a qualitative feature of the stimulus 
does not match the pattern in a previous series (Light and Braff, 2005) (Figure 5A). One core 
feature of MMN is the importance of NMDA receptor function. For instance, non-competitive 
NMDA-R antagonists, like ketamine and the selective antagonist of the NR2B NMDA subunit, 
CP-101,606 reduce MMN amplitude (Sivarao et al., 2014), the level of which predicts the 
magnitude of psychotic experiences in response to these drugs (Umbricht et al., 2002). 
Therefore, in order to probe this function further here, mice were given either saline or 10mg/kg 
of ketamine prior to the MMN test. 
In saline treated animals there was a difference between Ehmt1D6Cre/+ and Ehmt1fl/+ mice in 
response to the deviant pulse (Figures 5C-D) as indicated by analysis of the N1 amplitude that 
showed an interaction between GENOTYPE and PULSE (repeated measures ANOVA, 
F1,8=12.70, p=0.007). In the standard pulse condition Ehmt1fl/+ mice, amplitude corresponded to 
an increase in ~10-40Hz evoked potential approximately 30-50ms post-stimulus (Figure. 5C1-
C2). In the deviant pulse condition, Ehmt1fl/+ mice not only show an increase in ~10-40Hz 
evoked potential, but also one with greater peak latency, at 40-70ms post-stimulus (Figure 5C2). 
In contrast, Ehmt1D6Cre/+ mice treated with saline showed no pattern of change in the amplitude 
response for either standard or deviant pulses. 
However, following 10mg/kg of ketamine administration, the difference in the N1 amplitude 
between the standard and deviant pulse was absent for both genotypes (Figure 5B and D), as 
indicated by a lack of interaction between GENOTYPE and PULSE (repeated measures 
ANOVA, F1,7=0.011, p=0.921). Further analysis underlined this finding. Permutation tests after 
saline administration for the deviant-only condition demonstrates a difference between Ehmt1fl/+ 
controls and Ehmt1D6Cre/+ wavelet transforms, at 30Hz between 50-80ms post-stimulus (Figure 
5E1), driven by the higher amplitude response in the Ehmt1fl/+ control mice.  In contrast, after 
ketamine administration the difference in deviant response between Ehmt1fl/+ controls and 
Ehmt1D6Cre/+ mice was abolished (Figure 5E2). 
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Altered NMDA-receptor expression in Ehmt1D6cre/+ mutant mice 
In light of similarity in basal Ehmt1D6Cre/+ electrophysiological phenotype and the 
electrophysiological phenotype in Ehmt1fl/+ control mice following ketamine administration, we 
assessed the NMDA system in Ehmt1D6Cre/+ mice. RT qPCR was used to examine the mRNA  
 
Figure 5. AEP mismatch negativity phenotypes & NMDA mRNA expression. A) Mismatch negativity 
stimulus B) Grand average ERP waveforms (shaded areas) after the saline or ketamine conditions in the in 
Ehmt1fl/+ (n=5) and Ehmt1D6Cre/+ (n=5), for the deviant (red) and standard (black) tone for each condition.  C1 & 
C2) Time-frequency plot of evoked power for the standard and deviant pulse in Ehmt1fl/+ mice after saline 
injection; C3 & C4) Time-frequency plot of evoked power for the standard and deviant pulse in Ehmt1D6Cre/+mice 
following saline injection.  D) N1 amplitude peak amplitude corresponding to each condition. E1) Permutation 
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test showing heat map of p-values for the difference of distribution between deviant tone maps of saline treated 
Ehmt1fl/+ (C2) and Ehmt1D6Cre/+ (C4). E2) Permutation test showing heat map of p-values for the difference of 
distribution between deviant tone maps of ketamine treated Ehmt1fl/+ (C2) and Ehmt1D6Cre/+ (C4). F) NMDA-R 
subunit mRNA expression in hippocampal samples (Ehmt1fl/+ n=4, Ehmt1D6Cre/+ n=8). Data shown is mean ±SEM. 
* represents main effect of GENOTYPE p<0.05. 
levels of NMDA-R subunits Grin1, Grin2a, Grin2b and Grin2c in the adult hippocampus. 
Expression of Grin1, the gene encoding NMDA NR1 subunit, was significantly reduced by 40% 
on average in Ehmt1D6cre/+ mice (Figure 5F; t=-3.07, p=0.014). No difference was seen in 
expression of other NMDA-R subunits examined (Figure 5F Grin2a, t=-1.02, p=0.331; Grin2b, 
t=-0.814, p=0.435; or Grin2c, t=-0.71, p=0.498). Furthermore, there were no genotype 
differences in AMPA-R subunit gene expression examined (See Supplementary Figure 4). 
 
DISCUSSION 
Recent studies in human genomics strongly implicate a number of genes found to regulate 
chromatin dynamics in the etiology of neurodevelopmental disorders from developmental delay 
(Singh et al., 2016), to autism spectrum disorders (RK et al., 2017, De Rubeis et al., 2014), and 
schizophrenia (Network and Pathway Analysis Subgroup of Psychiatric Genomics, 2015). 
EHMT1 is one such gene, associated with both neurodevelopmental and neuropsychiatric 
disorders. Here we examined behavioural and electrophysiological correlates of information 
processing in a mouse model of Ehmt1 haploinsufficiency, specifically in the forebrain. We 
found that Ehmt1D6Cre/+ mice have sensorimotor and auditory gating deficits, reduced anxiety, 
and learning and memory deficits, in the absence of generic deficits in motor function. 
Ehmt1D6Cre/+ mice also showed a number of abnormalities in electrophysiological measurements 
including a reduced magnitude of AEPs after paired-pulse inhibition and MMN tasks, reduced 
evoked and total power in high frequency bands, and reduce PLF. Overall these data indicate that 
Ehmt1D6Cre/+ mice show deficits in sensory motor gating and information process, possibly 
related to abnormal NMDA-R functioning. 
Ehmt1D6Cre/+ mice displayed decreased anxiety in a number of measures across a two separate 
tests, namely the EPM and OF. Although these findings in our model were not confounded by 
impaired motor competence as indicated by normal behaviour and learning on the rotarod test, 
not all measures on both the EPM and OF reached statistical significance. It may be that a more 
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robust assessment of anxiety in this model would be achieved using a unified score from a 
number of separate measures (Harrison et al., 2020). Generally however, these findings of 
decreased anxiety are consistent with previous studies of Ehmt1 haploinsufficient models 
(Iacono et al., 2018, Balemans et al., 2010), although other models, specifically a CamKII-drive 
full Ehmt1 deletion shows decreased anxiety (Schaefer et al., 2009). This indicates that the 
relationship between Ehmt1 function and anxiety behaviour probably depends on extent, timing 
and location of the genetic lesion. 
EHMT1 is a risk gene associated with a number of neurodevelopmental and psychiatric disorders 
(Talkowski et al., 2012), thus it was important for this work to focus not only on translational 
phenotypes but those that overlap traditional diagnostic boundaries.  Several prominent features 
shared by these disorders are associated with deficits in attention and gating, or filtering out 
intrusive stimuli (Javitt, 2009, Orekhova et al., 2008, Perry et al., 2007, Belmonte et al., 2004). 
Behaviorally, the Ehmt1D6Cre/+ mice showed evidence of this in an acoustic startle test. Consistent 
with previous findings in other Ehmt1 haploinsufficiency models (Iacono et al., 2018, Balemans 
et al., 2013), sensory motor gating deficits were manifest by both a greatly enhanced acoustic 
startle response, and a decreased pre-pulse inhibition of startle.  
Information-processing deficits are another common phenotype associated with EHMT1 risk 
populations. Accordingly, Ehmt1D6Cre/+ mice were examined on their performance in the NOR 
task, a paradigm where an animal's ability to remember a previously encountered object is 
indicated by an increased willingness to explore the novel object over the familiar object. The 
Ehmt1D6Cre/+ mice showed no evidence of novel object recognition, even with only a 15-minute 
interval after habituation. Importantly, this was not due to reduced interest in exploration or 
exposure to the familiar object, as time spent in exploration was equivalent across Ehmt1fl/+ 
control and Ehmt1D6Cre/+ mutant mice. Similarly to the acoustic startle and prepulse inhibition 
phenotype, deficits in a NOR paradigm have been seen in other Ehmt1+/- mice (Iacono et al., 
2018, Balemans et al., 2013). This convergence across models and laboratories suggests that 
both sensory motor-gating and information processing deficits are key behavioural features of 
Ehmt1 haploinsufficiency. 
Given the robustness of behavioural deficits in sensory motor-gating and information processing 
seen in models of Ehmt1 haploinsufficiency, we explored this further by examining 
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electrophysiological measures of these domains.  Ehmt1D6Cre/+ had reduced N1 amplitude in 
response to stimulus 1 (S1). Furthermore, Ehmt1D6Cre/+ mice had a significant reduction in the 
S2/S1 ratio for the N1 component, an electrophysiological correlate of sensory gating. 
Evidence of information-processing deficits in the Ehmt1D6Cre/+ mice was provided by the 
reduced response in a mismatch negativity (MMN) paradigm. The decreased amplitude 
responses in these AEP measurements meanwhile corresponded to significant reductions in total 
and evoked power in high frequency bands. Such reductions may be particularly insightful, as 
numerous studies report disruptions in gamma-band activity across neurodevelopment 
(Orekhova et al., 2008, Kwon et al., 1999), neuropsychiatric (Tatard-Leitman et al., 2015) and 
neurodegenerative diseases (Iaccarino et al., 2016). Whether reduced gamma activity is actually 
directly associated with disease pathologies across these patient populations remains largely 
unknown.  Recently however, reductions in gamma-band activity were found to precede the 
onset of plaque formations and cognitive decline in a mouse model of Alzheimer’s disease. 
Meanwhile the stimulation of fast-spiking interneurons in the gamma frequency range (~40Hz), 
a way to boost gamma-band activity (Cardin et al., 2009), led to the reduction in the plaque 
forming amyloid isoforms and attenuated plaque load in ageing mice (Iaccarino et al., 2016). In a 
more functional assessment, the induction of long-term potentiation using high frequency 
stimulation (~100Hz) was found to restore spine density and long-term memory in early stages 
of the disease in mice (Roy et al., 2016). While these findings are specific to Alzheimer’s 
disease, they also confirm an important link between gamma synchrony and cognitive function 
exists (Fries, 2015). Furthermore, we may find disruptions in high frequency oscillation patterns 
tightly correspond with the degree of cognitive impairment and range of pathologies across 
EHMT1 risk populations.   
The decreases in high frequency activity coupled with reduced Grin1 mRNA are suggestive of 
overall disruptions in local connectivity and may hint to more global imbalances in 
excitation/inhibition (E/I). Such findings do corroborate previous reports showing abnormalities 
in neural development and connectivity in Ehmt1+/- mouse models (Benevento et al., 2017, 
Balemans et al., 2014, Balemans et al., 2013), and that Ehmt1-mediated H3K9me2 levels 
dynamically regulate synaptic scaling, thus playing a direct role in the fine balance between 
excitation and inhibition at the level of individual neurons (Benevento et al., 2016). And indeed 
many of the Ehmt1D6Cre/+ mice phenotypes are markedly similar to Grin1 mouse mutants (Furuse 
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et al., 2010). The Grin1neo-/- mice and the Grin1Rgsc174 heterozygous mice both show increased 
stereotypy (Mohn et al., 1999) and deficits in sensorimotor gating (Duncan et al., 2004). Mice 
with even subtle reductions in the NR1 receptor are found to have decreases in MMN 
(Featherstone et al., 2015), gamma-band disruptions and reduction in E/I balance (Gandal et al., 
2012). Nevertheless, it is important to note that the studies presented here represent a change in 
mRNA and not protein levels and, moreover, only provide a correlative link between the 
electrophysiological deficits seen in Ehmt1D6Cre/+ mice and Grin1 reduction. Interestingly 
however, a recent study has demonstrated increased Grin1 expression and NMDA-R 
hyperactivity in iPS cells derived from Kleefstra syndrome patients (Frega et al., 2019). Despite 
the discrepancies, together these data suggest that future investigation of Ehmt1 
haploinsufficiency may benefit from further examination of the relationship with the NMDA 
system. 
In summary, Ehmt1D6Cre/+ forebrain-specific haploinsufficiency produced deficits in sensory-
gating and information processing. Behavioural evidence from explicit tests of sensorimotor 
gating and findings from a learning and memory task, suggest that Ehmt1D6Cre/+ mice do not 
attend to or process information in order to inform appropriate behavioural responses. Neural 
correlates of these abnormalities were further demonstrated using electrophysiological studies, 
which indicated deficits related to disruptions in local connectivity and NMDA function. Taken 
together these data suggest that Ehmt1 haploinsufficiency leads to abnormal circuit formation 
and behavioural abnormalities that likely underpin deficits seen across the broad spectrum of 
neurodevelopmental and neuropsychiatric disorders with which EHMT1 is associated. 
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